Ignite Creation Date:
2024-05-06 @ 8:29 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06392503
Status:
RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-04-26
Brief Title:
Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis
Sponsor:
Beijing 302 Hospital
Organization:
Beijing 302 Hospital
Study Overview
Official Title:
Establishment of Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis Patients Based on iLivTouch
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NID-HRV
Brief Summary:
This is an observational ambispective cohort study to validate the Baveno VI guideline and develop a new diagnostic model to screen high-risk varices HRV of liver cirrhosis using iLivTouch
Detailed Description:
Esophageal variceal bleeding is a common and fatal complication in patients with liver cirrhosis The diagnosis of high-risk varices HRV traditionally depends on gastroscopy which is expensive and poorly tolerated with patients Baveno VI guideline has put forward a HRV screening model based on liver stiffness and platelet count This is an observational ambispective cohort study The retrospective cohort is derived from the previous records of the hospital information system and the prospective cohort is enrolled prospectively at the local research center when participants meet the inclusion criteria The purpose of this study is to establish a diagnostic model of HRV in patients with liver cirrhosis according to the liver stiffness value measured by iLivTouch and other laboratory indexes so as to verify the applicability of Baveno VI standard under the condition of iLivTouch and establish a cutoff value that is more suitable for iLivTouch In addition this study will try to find some new indexes to further improve the diagnostic efficiency of HRV The minimum enrolment period is anticipated to be 6 months per center and will be extended if necessary to reach the overall study target
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None